Recent Finacing
Recent Raise
Solve Therapeutics develops next-generation antibody-drug conjugates (ADCs) for treating solid tumors using its proprietary CloakLink™ hydrophilic linker technology.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
